awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37130325-40099700-9047-4FF1-B2B8-EB87A163115C
Q37130325-40099700-9047-4FF1-B2B8-EB87A163115C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37130325-40099700-9047-4FF1-B2B8-EB87A163115C
Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design.
P1476
Q37130325-40099700-9047-4FF1-B2B8-EB87A163115C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37130325-40099700-9047-4FF1-B2B8-EB87A163115C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55f4cfe1a81455add743f1e19fe2c4dff56bfa59
P1476
Disease flare after tyrosine k
......
ions for clinical trial design
@en